Funded Tech Companies
Protalix BioTherapeutics
Operating out of Carmiel, Protalix BioTherapeutics is venture-backed, with investment from Alrov, UBS and Psagot Investment House.
Company Overview
Company Name
Protalix BioTherapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2 Snunit St. Science Park POB 455
Carmiel, 2161401
Israel
Carmiel, 2161401
Israel
Phone
Website
Email Address
Company Background Information
Overview
Protalix is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by our proprietary ProCellEx plant cell-based protein expression system.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/13/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dror Bashan
Chief Financial Officer
Eyal Rubin
Chief Medical Officer
Raul Chertkoff
VP - Bus. Development
William Taylor
VP - Engineering
Moshe Chechik
VP - Human Resources
Dafna Shelly
VP - Operations
Yaron Naos
VP - Product Management
Einat Brill-Almon
VP - Product Management
Ronen Rosenberg
VP - Regulatory Affairs
Michal Kahana
Company Investors
- Alrov
- UBS
- Psagot Investment House
- Rosalind Capital
- Highbridge Capital Management
- More Investment House
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs